Smad proteins and transforming growth factor-β signaling

Kidney International, Supplement

Volumn 58, Issue 77, 2000, Pages

  Schiffer, M ^a   Von Gersdorff, G ^a   Bitzer, M ^a   Susztak, K ^a   Bottinger, E P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Gene regulation; Kidney; Signal transduction; Smad; Transcription; Transforming growth factor

Indexed keywords

CYTOKINE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; DNA BINDING PROTEIN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

FIBROGENESIS; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; INFLAMMATORY CELL; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY TUBULE DAMAGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOSKELETON; GENETIC TRANSCRIPTION; HUMAN; KIDNEY; PHYSIOLOGY;

ANIMALS; CYTOSKELETON; DNA-BINDING PROTEINS; HUMANS; KIDNEY; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033858467     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07708.x     Document Type: Review

References (59)

1. Metanephric transforming growth factor-beta 1 regulates nephrogenesis in vitro
2. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells
3. Extracellular matrix-related genes in kidney after ischemic injury: Potential role for TGF-beta in repair
4. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
5. TGF-beta and the endothelium during immune injury
6. Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase
7. Transforming growth factor-β1 inhibits type I inositol 1,4,5-trisphosphate receptor expression and enhances its phosphorylation in mesangial cells
8. Peptide growth factors are multifunctional
9. Immunoregulation, TGF beta 1. Suppression of a nephritogenic murine T cell clone
10. TGF-beta and glomerulonephritis: Anti-inflammatory versus prosclerotic actions
11. Transforming growth factor beta in tissue fibrosis
12. Role of transforming growth factor beta in diabetic nephropathy
13. Transforming growth factor-β in renal disease
14. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
15. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis
16. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats
17. Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation
18. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse
19. Lessons from TGF-beta transgenic mice
20. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells
21. Role of transforming growth factor-β 1 in experimental chronic cyclosporine nephropathy
22. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta
23. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells
24. Transforming growth factor-beta1 stimulates protein kinase A in mesangial cells
25. TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression
26. Transforming growth factor beta 1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages
27. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
28. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components
29. TGF-beta signal transduction
30. Signaling inputs converge on nuclear effectors in TGF-beta signaling
31. The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-beta receptors
32. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
33. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways
34. Dual role of the Smad4/DPC4 tumor suppressor in TGF beta-inducible transcriptional complexes
35. Human Smad3 and Smad4 are sequence-specific transcription activators
36. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
37. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
38. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling
39. Xenopus Smad4β is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes
40. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium
41. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
42. Smad6 inhibits signalling by the TGF-beta superfamily
43. Microtubule binding to Smads may regulate TGF beta activity
44. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor
45. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
46. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA
47. Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2 (I) collagen gene transcription
48. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway
49. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1
50. A mechanism of repression of TGFβ/ Smad signaling by oncogenic Ras
51. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells
52. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases
53. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells
54. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation
55. Ubiquitin-dependent degradation of TGF-beta-activated Smad2
56. Regulation of Smad7 promoter by direct association with Smad3 and Smad4
57. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor b
58. Assignment of the Smad7 gene (MADH7) to human chromosome 18q21.1 by fluorescence in situ hybridization
59. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain